Viewing Study NCT03053167

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-26 @ 12:21 AM
Study NCT ID: NCT03053167
Status: UNKNOWN
Last Update Posted: 2017-02-14
First Post: 2017-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
Sponsor: China Medical University, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ColoRectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Raltitrexed View
None Irinotecan View
None Second-line Treatment View
None Advanced Colorectal Cancer(ACC) View